72790-89-7 Usage
Uses
Due to the limited information available on 1-Methylcyclopropanecarbohydrazide, its uses are not well-established. However, based on its chemical structure and the properties of similar compounds, potential applications can be hypothesized:
Used in Pharmaceutical Industry:
1-Methylcyclopropanecarbohydrazide could be used as an intermediate in the synthesis of pharmaceutical compounds for various therapeutic applications. The hydrazide group may allow for the formation of hydrazones, which are known to have potential in medicinal chemistry.
Used in Chemical Research:
As a member of the hydrazide family, 1-Methylcyclopropanecarbohydrazide may be utilized in academic or industrial research settings to study the reactivity and properties of hydrazides. This could lead to the development of new synthetic methods or the discovery of novel chemical reactions.
Used in Material Science:
The unique structure of 1-Methylcyclopropanecarbohydrazide may offer potential applications in the development of new materials with specific properties, such as polymers or coordination compounds. The cyclopropane ring and hydrazide group could contribute to the formation of novel structures with potential uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 72790-89-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,7,9 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 72790-89:
(7*7)+(6*2)+(5*7)+(4*9)+(3*0)+(2*8)+(1*9)=157
157 % 10 = 7
So 72790-89-7 is a valid CAS Registry Number.
InChI:InChI=1/C5H10N2O/c1-5(2-3-5)4(8)7-6/h2-3,6H2,1H3,(H,7,8)
72790-89-7Relevant academic research and scientific papers
Development of orally active nonpeptidic inhibitors of human neutrophil elastase
Ohmoto,Yamamoto,Okuma,Horiuchi,Imanishi,Odagaki,Kawabata,Sekioka,Hirota,Matsuoka,Nakai,Toda,Cheronis,Spruce,Gyorkos,Wieczorek
, p. 1268 - 1285 (2007/10/03)
5-Amino-2-phenylpyrimidin-6-ones, some of their desamino derivatives, and miscellaneous derivatives were synthesized and biologically evaluated on both in vitro activity and oral activity in an acute hemorrhagic assay. These compounds contained an α-keto-1,3,4-oxadiazole moiety to bind covalently to the Ser-195 hydroxy group of human neutrophil elastase (HNE). Among those tested, compounds 11a-c,e,i-l(F), 11d,e,k(H), 21d,e,k(F), and 21d,e(H) showed a good oral profile. RS-Mixture 3(H) was selected for clinical evaluation based on its oral potency, duration of action, enzyme selectivity, safety profile, and ease of synthesis. Structure -activity relationships (SARs) are discussed.
